Delphic is a specialist laboratory company with particular expertise in infectious diseases, and with capabilities in study design, method development and method transfer in a range of other therapy areas. Delphic was the first company in the world to offer a dedicated integrated diagnostics service for HIV providing the full suite of tests that made individualised care 'standard of care' in the UK.

The company is advised by and employs senior scientists and clinical key opinion leaders giving it world-leading expertise in pharmacology and pharmacogenetics. Its laboratories are certified to ISO, GCLP and CAP and its CLIA registration enables it to receive samples from North America.

Delphic has global reach with its own laboratories in the UK and partner laboratories in Italy, Spain, Greece, Argentina and the US. It has applied its clinical and scientific expertise to its clinical trials portfolio and is able to process rapid batched samples, or to design, manage and deliver patient-focused trials.